National Cervical Screening Program: Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding

From Clinical Guidelines Wiki


Two sections of the guideline, HPV oncogenic types not 16/18 and Self-collected vaginal samples have been reviewed and updated. Updated guidance came into effect on 1 February 2021.

For further information, see: Review of National Cervical Screening Program data and partial update.
To be notified about the launch of updated guideline content, contact guidelines(at)cancer.org.au.

National Cervical Screening Program DoH logo.JPG

Endorsed by RCPA logo for wiki.JPG

RANZCOG RGB.jpg

ASGO (Aust) Prefered Logo.jpg

ASCCP logo-final.jpg


Clinical management guidelines for the prevention of cervical cancer

Foreword

Introduction

Summary of recommendations

1. Cervical cancer in Australia

2. The rationale for primary HPV screening

3. Terminology

4. Unsatisfactory cervical screening results

5. Benefits, harms and cost-effectiveness of cervical screening

6. Management of oncogenic HPV test results

7. Colposcopy

8. Management of discordant colposcopic impression, histopathology and referral LBC prediction

9. Management of histologically confirmed low-grade squamous abnormalities

10. Management of histologically confirmed high-grade squamous abnormalities

11. Management of glandular abnormalities

12. Screening in Aboriginal and Torres Strait Islander women

13. Screening after total hysterectomy

14. Screening in pregnancy

15. Screening in women who have experienced early sexual activity or have been victims of sexual abuse

16. Screening in immune-deficient women

17. Screening in DES-exposed women

18. Signs and symptoms of cervical cancer

19. Psychosocial care

20. Transition to the renewed National Cervical Screening Program

Appendices


Please see the Australian Department of Health Cancer Screening website for information about the National Cervical Screening Program (NCSPNational Cervical Screening ProgramA joint program of the Australian, state and territory governments. It aims to reduce morbidity and mortality from cervical cancer, in a cost-effective manner through an organised approach to cervical screening. The program encourages women in the target population to have regular Pap smears.) and policies on transitioning women to the renewed NCSPNational Cervical Screening ProgramA joint program of the Australian, state and territory governments. It aims to reduce morbidity and mortality from cervical cancer, in a cost-effective manner through an organised approach to cervical screening. The program encourages women in the target population to have regular Pap smears..


Resources

Cervical cancer screening online education modules (e-learning)


Back to top